Dr. James Duncan Kellner
Positions
Professor - Medicine
Cumming School of Medicine, Department of Pediatrics | Infectious Diseases
Full Member
Alberta Children's Hospital Research Institute
Full Member
O'Brien Institute for Public Health
Associate Member
The Calvin, Phoebe and Joan Snyder Institute for Chronic Diseases
Affiliations
Cross Appointment
Cumming School of Medicine, Department of Microbiology, Immunology and Infectious Diseases
Cross Appointment
Cumming School of Medicine, Department of Community Health Sciences
Contact information
Background
Educational Background
BSc Science, University of Alberta, 1981
Doctor of Medicine Medicine, University of Calgary, 1984
MSc Clinical Epidemiology, University of Toronto, 1998
Biography
Dr. Jim Kellner is a pediatrician, clinical investigator and medical leader with extensive local and national experience related to child health, infectious diseases and research. He started his career as a pediatric emergency medicine specialist, and then became a specialist in pediatric infectious diseases. For more than 25 years, he has worked with colleagues from health service professions and basic sciences in epidemiologic research and clinical trials focused on vaccine preventable infections with a particular focus on Streptococcus pneumoniae infections. Dr. Kellner established two local research teams and is a member of several national and international research networks.
As a medical leader, Dr. Kellner was Chair/Chief of the Department of Pediatrics at the University of Calgary and Calgary Zone of Alberta Health Services from 2008 to 2018. During this decade, the department grew by 75% leading to very significant expansion of clinical, education and research services. As Chair/Chief, he served with national organizations related to child health, including the Paediatric Chairs of Canada (serving as President from 2013-2016), and the Board of Directors of the Canadian Association of Pediatric Health Centres (now known as Children’s Healthcare Canada).
During the COVID-19 pandemic, Dr. Kellner was a member of the federal COVID-19 Immunity Task Force Leadership Group and was Co-Chair of the CITF’s Field Studies Working Party and Lead of the Pediatric Network. As an investigator, he led or participated in numerous local and national clinical and epidemiologic studies, vaccine clinical trials and vaccine safety studies.
Research
Areas of Research
Clinical and molecular epidemiology, and vaccine clinical trials related to Streptococcus pneumoniae (pneumococcus), SARS-CoV-2 (COVID-19), influenza, Neisseria meningiditis (meningococcus), Human papillomavirus (HPV).
PI ACHIEVE (Alberta Children's Hospital Infectious Diseases Epidemiology and Vaccine Evaluation) Research Team and CASPER (Calgary S. pneumoniae Epidemiology Research) Team.
Participation in university strategic initiatives
Publications
Are you the profile owner?
Login to edit.